Clinical Controlled Study on the Efficacy of Denosumab in Treating Osteoporosis in the Domestic Population and Its Impact on Sarcopenia-related Outcomes
This clinical trial aims to evaluate the efficacy of Denosumab in treating osteoporosis and its impact on sarcopenia in a domestic population. The study involves a randomized controlled design with an estimated enrollment of 86 participants, comparing Denosumab treatment against a placebo over a 12-month period.
Indication: Sarcopenia
Modality: monoclonal antibody
Target: Osteoporosis and Sarcopenia
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Source URL: ClinicalTrials.gov
Source updated: Aug 16, 2024
Ingested: May 23, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Osteoporosis and Sarcopenia
View original source fields
Condition raw: Sarcopenia
Condition normalized: Sarcopenia
Modality raw: Sarcopenia
Modality normalized: monoclonal antibody
Target raw: Osteoporosis and Sarcopenia
Target normalized: Osteoporosis and Sarcopenia